Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

240 та иш

Иш: The key role of microRNA-766 in the cancer development

  1. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma

    Hamed Mirzaei, Sharareh Gholamin, Soodabeh Shahidsales +5

    Шарҳ мақола20152 иқтибос
    ABI
  2. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies

    Reza Salarinia, Amirhossein Sahebkar, Mostafa Peyvandi +10

    Шарҳ мақола20162 иқтибос
    ABI
  3. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers

    Leila Saadatpour, Elyas Fadaee, Sara Fadaei +6

    Шарҳ мақола20162 иқтибос
    ABI
  4. MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy

    Hamed Mirzaei, Fatemeh Momeni, Leila Saadatpour +7

    Шарҳ мақола20172 иқтибос
    ABI
  5. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers

    Khodayar Golabchi, Rahim Soleimani‐Jelodar, Nazila Aghadoost +6

    Шарҳ мақола20172 иқтибос
    ABI
  6. Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome

    Mohammad Javad Saeedi Borujeni, Ebrahim Esfandiary, Gholamreza Taheripak +3

    Шарҳ мақола20172 иқтибос
    ABI
  7. Cytokines and MicroRNA in Coronary Artery Disease

    Hamed Mirzaei, Gordon A. Ferns, Amir Avan +1

    Шарҳ мақола20172 иқтибос
    ABI
  8. MiR‐21: A key player in glioblastoma pathogenesis

    Mohammad Sadegh Masoudi, Emadodin Mehrabian, Hamed Mirzaei

    Шарҳ мақола20172 иқтибос
    ABI
  9. Stroke in Women: Risk Factors and Clinical Biomarkers

    Hamed Mirzaei

    Шарҳ мақола20172 иқтибос
    ABI
  10. Circulating miR-21 as novel biomarker in gastric cancer

    Miganoosh Simonian, Meysam Mosallayi, Hamed Mirzaei

    Бошқа20182 иқтибос
    ABI
  11. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis

    Ehsan Javandoost, Ehsan Firoozi-Majd, Hosein Rostamian +2

    Шарҳ мақола20192 иқтибос
    ABI
  12. Plant-based vaccines and cancer therapy: Where are we now and where are we going?

    Neda Rahimian, Hamid Reza Miraei, Atefeh Amiri +6

    Шарҳ мақола20212 иқтибос
    ABI
  13. The lncRNA NEAT1/miRNA-766-5p/E2F3 Regulatory Axis Promotes Prostate Cancer Progression

    Wenhui Zhao, Xinshu Zhu, Jin Qiu +2

    Мақола20222 иқтибос
    ABI
  14. Effects of Micrornas and Long Non-Coding RNAs on Chemotherapy Response in Glioma

    Sara Ahmadpour, Tarannomsadat Taghavi, Amirhossein Sheida +3

    Шарҳ мақола20222 иқтибос
    ABI
  15. Metabolic reprogramming and cancer progression

    Brandon Faubert, Ashley Solmonson, Ralph J. DeBerardinis

    Шарҳ мақола20202 иқтибос
    ABI